Widening the Horizons of Oligonucleotide Drug Platforms

Endpoints news article

Utilizing DealForma’s data, Nature’s article showcases selected deals focusing on cardiovascular diseases, CNS disorders, and the oligonucleotide therapies driving these advancements.

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures